Resident’s Forum
RF-New Evidence in Favor of 5-Fluorouracil in the Treatment of Actinic Keratosis
FR-Nueva evidencia a favor de 5-fluorouracilo en eltratamiento de las queratosis actínicas
D. Morgado-Carrasco
, X. Fustà-Novell, A. Toll
Autor para correspondencia
Servicio de Dermatología, Hospital Clínic de Barcelona, Barcelona, España
Leído
5957
Vecesse ha leído el artículo
2272
Total PDF
3685
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 62 | 10 | 72 |
| 2025 5 | 149 | 28 | 177 |
| 2025 4 | 140 | 28 | 168 |
| 2025 3 | 140 | 23 | 163 |
| 2025 2 | 151 | 50 | 201 |
| 2025 1 | 83 | 24 | 107 |
| 2024 12 | 74 | 26 | 100 |
| 2024 11 | 90 | 48 | 138 |
| 2024 10 | 74 | 39 | 113 |
| 2024 9 | 85 | 22 | 107 |
| 2024 8 | 105 | 52 | 157 |
| 2024 7 | 91 | 33 | 124 |
| 2024 6 | 97 | 29 | 126 |
| 2024 5 | 77 | 38 | 115 |
| 2024 4 | 81 | 37 | 118 |
| 2024 3 | 71 | 40 | 111 |
| 2024 2 | 59 | 23 | 82 |
| 2024 1 | 56 | 33 | 89 |
| 2023 12 | 63 | 24 | 87 |
| 2023 11 | 80 | 43 | 123 |
| 2023 10 | 67 | 23 | 90 |
| 2023 9 | 46 | 27 | 73 |
| 2023 8 | 39 | 15 | 54 |
| 2023 7 | 55 | 35 | 90 |
| 2023 6 | 51 | 20 | 71 |
| 2023 5 | 51 | 26 | 77 |
| 2023 4 | 45 | 38 | 83 |
| 2023 3 | 59 | 32 | 91 |
| 2023 2 | 45 | 29 | 74 |
| 2022 1 | 59 | 54 | 113 |
| 2022 12 | 59 | 54 | 113 |
| 2022 11 | 23 | 36 | 59 |
| 2022 10 | 35 | 25 | 60 |
| 2022 9 | 27 | 36 | 63 |
| 2022 8 | 23 | 45 | 68 |
| 2022 7 | 24 | 41 | 65 |
| 2022 6 | 29 | 39 | 68 |
| 2022 5 | 59 | 54 | 113 |
| 2022 4 | 78 | 42 | 120 |
| 2022 3 | 79 | 79 | 158 |
| 2022 2 | 63 | 45 | 108 |
| 2021 1 | 59 | 54 | 113 |
| 2021 12 | 61 | 53 | 114 |
| 2021 11 | 62 | 62 | 124 |
| 2021 10 | 80 | 80 | 160 |
| 2021 9 | 54 | 64 | 118 |
| 2021 8 | 50 | 44 | 94 |
| 2021 7 | 51 | 48 | 99 |
| 2021 6 | 37 | 66 | 103 |
| 2021 5 | 55 | 66 | 121 |
| 2021 4 | 119 | 112 | 231 |
| 2021 3 | 64 | 57 | 121 |
| 2021 2 | 74 | 69 | 143 |
| 2020 1 | 51 | 40 | 91 |
| 2020 12 | 24 | 12 | 36 |
Mostrar todo
